Researchers examined 28 heart transplant patients who were diagnosed with COVID-19 at a healthcare facility in New York City. The study includes data for the patients from March 1 to April 24.
Overall, seven of the 28 heart transplant patients (25 percent) died.
Of the 28 patients, 22 were admitted to the hospital for treatment, and most had evidence of myocardial injury and elevated inflammatory biomarkers. About 25 percent of those admitted needed mechanical ventilation.
More articles on cardiology:
Estimated volume losses for 30 service lines
‘We are open, please come’: California hospital urges patients to seek emergency care
White House tables CDC reopening guidelines; hospitals question transparency of remdesivir distribution — 8 updates
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.